Latest News

Geriatric assessments improve oncologist-patient communications


 

REPORTING FROM ASCO 2018


Practices in arm 2 (controls) did not receive summaries or lists of recommendations, but oncologists were notified if patients had clinically significant depression or cognitive impairment.

In the intervention group, patients completed all assessments within 30 minutes, and less than 10 minutes of practice staff time was required for administration of objective tests.

The investigators made audio recordings and transcripts of clinic visits after GA in both arms, with two blinded coders evaluating quality of communication and plans for follow-up interventions. Patients were surveyed by telephone about their satisfaction, via the Health Care Climate Questionnaire (HCCQ) and the same instrument modified for age-related concerns (HCCQ-age).

“We found that patients enrolled in the study had a high prevalence of impairments of Geriatric Assessment domains, ranging from over 90% for physical performance, to 25% for psychological status, mainly depression. Of note, more than 30% of patients ... screened positive for cognitive impairment.” Dr. Mohile said.

Pages

Recommended Reading

CRC recurrence surveillance studies: No benefit to high-intensity strategy
MDedge Hematology and Oncology
New remote monitoring system lessens symptoms in head and neck cancer
MDedge Hematology and Oncology
FDA advisory panelists reject Buvaya for acute pain
MDedge Hematology and Oncology
CBT-I bests acupuncture for treating insomnia among cancer survivors
MDedge Hematology and Oncology
Ketorolac may reduce breast cancer recurrence risk, particularly in overweight patients
MDedge Hematology and Oncology
Dermatologic complaints prolong hospital stay for hematologic cancer
MDedge Hematology and Oncology
In CRC patients, chemo yields more toxicities in women than in men
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Tumor analysis: Test all MSI-high patients for Lynch Syndrome
MDedge Hematology and Oncology
David Henry’s JCSO podcast, May-June 2018
MDedge Hematology and Oncology